Strategic Capital Alternatives’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Strategic Capital Alternatives’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$12K	Buy	+115	New	+$13.7K	﹤0.01%	260

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TFA

Transamerica Financial Advisors St. Petersburg, Florida $1.17B AUM 23.36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Strategic Capital Alternatives's FBT Position: Q3 2015 in Review

Strategic Capital Alternatives opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2015: 115 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #260 among its holdings.

126 funds tracked by Wall St. Rank hold FBT as of Q3 2015.

Strategic Capital Alternatives held 115 shares of First Trust NYSE Arca Biotechnology Index Fund worth $12K as of Q3 2015.
First Trust NYSE Arca Biotechnology Index Fund was a new Strategic Capital Alternatives position in Q3 2015.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Strategic Capital Alternatives's portfolio in Q3 2015, its #260 holding.
126 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2015.

Based on Strategic Capital Alternatives's 13F filing for Q3 2015, filed 16 Nov 2015.